The African network for improved diagnostics, epidemiology and management of common infectious agents

Show simple item record

dc.contributor.author Schubert, Grit
dc.contributor.author Achi, Vincent
dc.contributor.author Ahuka, Steve
dc.contributor.author Belarbi, Essia
dc.contributor.author Bourhaima, Ouattara
dc.contributor.author Eckmanns, Tim
dc.contributor.author Johnstone, Siobhan L.
dc.contributor.author Kabore, Firmin
dc.contributor.author Kra, Ouffoue
dc.contributor.author Mendes, Adriano
dc.contributor.author Ouedraogo, Abdoul-Salam
dc.contributor.author Poda, Armel
dc.contributor.author Some, Arsene Satouro
dc.contributor.author Tomczyk, Sara
dc.contributor.author Couacy-Hymann, Emmanuel
dc.contributor.author Kayembe, Jean-Marie
dc.contributor.author Meda, Nicolas
dc.contributor.author Tamfum, Jean-Jacques Muyembe
dc.contributor.author Ouangraoua, Soumeya
dc.contributor.author Page, Nicola Anne
dc.contributor.author Venter, Marietjie
dc.contributor.author Leendertz, Fabian H.
dc.contributor.author Akoua-Koffi, Chantal
dc.date.accessioned 2022-02-09T09:11:27Z
dc.date.available 2022-02-09T09:11:27Z
dc.date.issued 2021-06-07
dc.description.abstract BACKGROUND : In sub-Saharan Africa, acute respiratory infections (ARI), acute gastrointestinal infections (GI) and acute febrile disease of unknown cause (AFDUC) have a large disease burden, especially among children, while respective aetiologies often remain unresolved. The need for robust infectious disease surveillance to detect emerging pathogens along with common human pathogens has been highlighted by the ongoing novel coronavirus disease 2019 (COVID-19) pandemic. The African Network for Improved Diagnostics, Epidemiology and Management of Common Infectious Agents (ANDEMIA) is a sentinel surveillance study on the aetiology and clinical characteristics of ARI, GI and AFDUC in sub-Saharan Africa. METHODS : ANDEMIA includes 12 urban and rural health care facilities in four African countries (Côte d’Ivoire, Burkina Faso, Democratic Republic of the Congo and Republic of South Africa). It was piloted in 2018 in Côte d’Ivoire and the initial phase will run from 2019 to 2021. Case definitions for ARI, GI and AFDUC were established, as well as syndromespecific sampling algorithms including the collection of blood, naso- and oropharyngeal swabs and stool. Samples are tested using comprehensive diagnostic protocols, ranging from classic bacteriology and antimicrobial resistance screening to multiplex real-time polymerase chain reaction (PCR) systems and High Throughput Sequencing. In March 2020, PCR testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and analysis of full genomic information was included in the study. Standardised questionnaires collect relevant clinical, demographic, socioeconomic and behavioural data for epidemiologic analyses. Controls are enrolled over a 12-month period for a nested case-control study. Data will be assessed descriptively and aetiologies will be evaluated using a latent class analysis among cases. Among cases and controls, an integrated analytic approach using logistic regression and Bayesian estimation will be employed to improve the assessment of aetiology and associated risk factors. DISCUSSION : ANDEMIA aims to expand our understanding of ARI, GI and AFDUC aetiologies in sub-Saharan Africa using a comprehensive laboratory diagnostics strategy. It will foster early detection of emerging threats and continued monitoring of important common pathogens. The network collaboration will be strengthened and site diagnostic capacities will be reinforced to improve quality management and patient care. en_ZA
dc.description.department Medical Virology en_ZA
dc.description.librarian am2022 en_ZA
dc.description.sponsorship The German Federal Ministry of Education and Research. Open Access funding enabled and organized by Projekt DEAL. en_ZA
dc.description.uri https://bmcinfectdis.biomedcentral.com en_ZA
dc.identifier.citation Schubert, G., Achi, V., Ahuka, S. et al. 2021, 'The african network for improved diagnostics, epidemiology and management of common infectious agents', BMC Infectious Diseases, vol. 21, art. 539, pp. 1-10. en_ZA
dc.identifier.issn 1471-2334 (online)
dc.identifier.other 10.1186/s12879-021-06238-w
dc.identifier.uri http://hdl.handle.net/2263/83704
dc.language.iso en en_ZA
dc.publisher BioMed Central en_ZA
dc.rights © The Author(s). 2021 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License. en_ZA
dc.subject Acute gastrointestinal infections en_ZA
dc.subject Sentinel surveillance en_ZA
dc.subject Aetiologies en_ZA
dc.subject Outbreak detection en_ZA
dc.subject Antimicrobial resistance en_ZA
dc.subject Coronavirus disease 2019 (COVID-19) en_ZA
dc.subject COVID-19 pandemic en_ZA
dc.subject Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) en_ZA
dc.subject Sub-Saharan Africa (SSA) en_ZA
dc.subject Acute respiratory infection (ARI) en_ZA
dc.subject Acute febrile disease of unknown cause (AFDUC) en_ZA
dc.title The African network for improved diagnostics, epidemiology and management of common infectious agents en_ZA
dc.type Article en_ZA


Files in this item

This item appears in the following Collection(s)

Show simple item record